A novelqacAallele results in an elevated chlorhexidine glu conate minimum inhibitory concentration in cutaneousStaphylococcus epidermidisisolates
AbstractChlorhexidine gluconate (CHG) is a topical antiseptic widely used in healthcare settings. InStaphylococcusspp., the pump QacA effluxes CHG, while the closely related QacB cannot due to a single amino acid substitution. We characterized 1,050 cutaneousStaphylococcusisolates obtained from 173 pediatric oncology patients enrolled in a multicenter CHG bathing trial. CHG susceptibility testing revealed 63 (6%) of these isolates had elevated CHG MICs (≥ 4 μg/mL). Screening of all 1,050 isolates forqacA/Bby restriction fragment length polymorphism (RFLP) yielded 56 isolates with a novelqacA/BRFLP pattern,qacAB273. The CHG MIC was significantly higher forqacAB273-positive isolates (MIC50: 4 μg/mL, [range: 0.5 – 4 μg/mL]) compared to otherqacgroups:qacA-positive (n=559, 1 μg/mL, [0.5 – 4 μg/mL]),qacB-positive (n=17, 1 μg/mL, [0.25 – 2 μg/mL]), andqacA/B-negative (n=418, 1 μg/mL, [0.125 – 2 μg/mL], p=0.001). TheqacAB273-positive isolates also displayed a high proportion of methicillin resistance (96.4%) compared to otherqacgroups (24.9 – 61.7%, p=0.001). Whole genome sequencing revealed thatqacAB273-positive isolates encoded a variant of QacA with 2 amino acid substitutions. This new allele, namedqacA4, was carried on the novel plasmid pAQZ1. TheqacA4-carrying isolates belonged to the highly resistantS. epidermidisclone ST2 and were collected from multiple centers across the United States and Canada. Curing an isolate ofqacA4resulted in a four-fold decrease in the CHG MIC, confirming the role ofqacA4in the elevated CHG MIC. Our results highlight the importance of further studyingqacA4and its functional role in clinical staphylococci.ImportanceStaphylococcus epidermidisis an important cause of infections in patients with implanted devices. Bathing with chlorhexidine gluconate (CHG), a topical antiseptic, has been shown to reduce rates of device-associated infections, especially those caused byS. epidermidis. InS. epidermidis, reduced susceptibility to CHG is associated with carriage of theqacAgene. As part of a multicenter CHG bathing trial, we obtained cutaneousStaphylococcusisolates from pediatric oncology patients across the United States and Canada. We identified a group of isolates capable of surviving in higher concentrations of CHG and determined a novel allele ofqacA, termedqacA4and carried on the novel plasmid pAQZ1, was responsible for the isolates’ survival in higher CHG concentrations. TheqacA4-carryingS. epidermidisisolates belonged to the highly resistant and virulent ST2 clonal type. Our results highlight the need to understand the global distribution of novelqacAalleles, includingqacA4, and their mechanistic effect on efflux.